Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients

Area of Science:

• Pharmacology
• Pediatric Surgery
• Antibiotic Dosing

Background:

• Cefazolin is a common antibiotic for preventing infections during surgery.
• Existing population pharmacokinetic (PK) models require refinement for pediatric dosing.
• Optimizing cefazolin doses in pediatric patients is crucial for effective perioperative prophylaxis.

Purpose of the Study:

• To refine a population pharmacokinetic (PK) model for cefazolin.
• To determine the ideal body weight cutoff for fixed cefazolin doses (1g or 2g) in pediatric surgery.
• To achieve cefazolin exposures in pediatric patients comparable to a 2g dose in adults.

Main Methods:

• Pooled pharmacokinetic data from 62 pediatric surgery patients (1102 plasma samples).
• Refined a previous PK model, simplifying it using allometrically scaled parameters.
• Utilized Monte Carlo simulations with the final PK model.

Main Results:

• A simplified and robust cefazolin population PK model was developed.
• The optimal weight cutoff for a 2g cefazolin dose in pediatric surgery was identified as 50 kg.
• Patients ≥50 kg should receive 2g, while those 25-49 kg should receive 1g.

Conclusions:

• The refined PK model provides a basis for optimized cefazolin dosing in pediatric surgery.
• A 50 kg weight cutoff is recommended for administering a 2g dose of cefazolin.
• This dosing strategy aims to ensure adequate cefazolin exposure in pediatric surgical patients.